[go: up one dir, main page]

UA110131C2 - ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ - Google Patents

ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ

Info

Publication number
UA110131C2
UA110131C2 UAA201312693A UAA201312693A UA110131C2 UA 110131 C2 UA110131 C2 UA 110131C2 UA A201312693 A UAA201312693 A UA A201312693A UA A201312693 A UAA201312693 A UA A201312693A UA 110131 C2 UA110131 C2 UA 110131C2
Authority
UA
Ukraine
Prior art keywords
treatment
arithmy
pirimidine
tiene
derivatives
Prior art date
Application number
UAA201312693A
Other languages
English (en)
Ukrainian (uk)
Inventor
Дерек Едвард Джон
Джон Форд
Original Assignee
Ксеншн Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44071904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA110131(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ксеншн Лімітед filed Critical Ксеншн Лімітед
Publication of UA110131C2 publication Critical patent/UA110131C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Данное изобретение касается соединений тиенопиримидина, которые являются ингибиторами калиевых каналов. Также описываются фармацевтические композиции, которые содержат указанные соединения, и их применение в лечении аритмии.
UAA201312693A 2011-04-01 2012-03-29 ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ UA110131C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1105659.5A GB201105659D0 (en) 2011-04-01 2011-04-01 Compounds
PCT/GB2012/050710 WO2012131379A1 (en) 2011-04-01 2012-03-29 Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia

Publications (1)

Publication Number Publication Date
UA110131C2 true UA110131C2 (ru) 2015-11-25

Family

ID=44071904

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201312693A UA110131C2 (ru) 2011-04-01 2012-03-29 ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ

Country Status (43)

Country Link
US (1) US9249155B2 (ru)
EP (1) EP2694518B1 (ru)
JP (1) JP5826374B2 (ru)
KR (1) KR20140023332A (ru)
CN (1) CN103492392B (ru)
AP (1) AP2013007198A0 (ru)
AR (1) AR088735A1 (ru)
AU (1) AU2012235882B2 (ru)
BR (1) BR112013025236A2 (ru)
CA (1) CA2831493A1 (ru)
CL (1) CL2013002789A1 (ru)
CO (1) CO6801756A2 (ru)
CR (1) CR20130488A (ru)
CU (1) CU24173B1 (ru)
CY (1) CY1117025T1 (ru)
DK (1) DK2694518T3 (ru)
EA (1) EA201301111A1 (ru)
EC (1) ECSP13012988A (ru)
ES (1) ES2558563T3 (ru)
GB (1) GB201105659D0 (ru)
GT (1) GT201300225A (ru)
HK (2) HK1193096A1 (ru)
HR (1) HRP20151340T1 (ru)
HU (1) HUE028438T2 (ru)
IL (1) IL228555A0 (ru)
MA (1) MA35064B1 (ru)
ME (1) ME02314B (ru)
MX (1) MX335937B (ru)
NI (1) NI201300100A (ru)
PE (1) PE20141021A1 (ru)
PH (1) PH12013501952A1 (ru)
PL (1) PL2694518T3 (ru)
PT (1) PT2694518E (ru)
RS (1) RS54458B1 (ru)
RU (1) RU2013148627A (ru)
SG (1) SG193578A1 (ru)
SI (1) SI2694518T1 (ru)
SM (1) SMT201500322B (ru)
TN (1) TN2013000377A1 (ru)
TW (1) TWI516265B (ru)
UA (1) UA110131C2 (ru)
WO (1) WO2012131379A1 (ru)
ZA (1) ZA201307085B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2922858A4 (en) * 2012-11-20 2016-06-15 Univ Mcgill THIENOPYRIMIDININHIBITORS OF FARNESYL AND / OR GERANYL GERANYL PYROPHOSPHATE SYNTHASE
US10221191B2 (en) 2015-12-22 2019-03-05 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
SG11201911929XA (en) 2017-06-21 2020-01-30 SHY Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH317906A (de) 1953-09-16 1956-12-15 Sandoz Ag Verfahren zur Herstellung von 1-Amino-4-oxyanthrachinonsulfonsäuren
AU521790B2 (en) 1977-05-23 1982-04-29 Ici Australia Limited Process for eradication of ticks
US4196207A (en) 1977-05-23 1980-04-01 Ici Australia Limited Process for controlling eradicating or preventing infestations of animals by Ixodid ticks
DD226893A1 (de) 1981-12-15 1985-09-04 Ralf Boehm Verfahren zur herstellung von arylaminosubstituierten thieno 2,3-d pyrimidinen
IL112569A (en) 1994-02-10 1999-12-22 Wyeth John & Brother Ltd Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
IL112567A (en) 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
IL112566A (en) 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
IL112568A0 (en) 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
CA2227384A1 (en) 1995-08-17 1997-02-27 Toshifumi Watanabe Thienopyrimidine derivatives, their production and use
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
SK7599A3 (en) 1996-07-26 1999-07-12 Nissan Chemical Ind Ltd Chroman derivatives and pharmaceutical composition containing the same
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
RU2116309C1 (ru) 1997-02-13 1998-07-27 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 4-[(бензо-2,1,3-тиадиазолил-4)амино]-5,6,7,8-тетрагидробензотиено [2,3-d]пиримидин, обладающий противогельминтной активностью при ларвальном альвеолярном эхинококкозе
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002517385A (ja) 1998-06-05 2002-06-18 イカゲン インク． カリウムチャネル阻害剤
WO2000012492A1 (en) 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US6194458B1 (en) 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AU766935B2 (en) 1999-09-17 2003-10-23 Nissan Chemical Industries Ltd. Benzopyran derivative
AU7319800A (en) 1999-09-24 2001-04-24 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
DE19947457A1 (de) 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en) 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
EP1218367A1 (en) 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
EP1240147A1 (en) 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors
JP4854909B2 (ja) 2000-09-20 2012-01-18 メルク・シャープ・エンド・ドーム・コーポレイション イソキノリノン系カリウムチャンネル阻害剤
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10059418A1 (de) 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10104802A1 (de) 2001-02-02 2002-08-08 Merck Patent Gmbh Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1)
WO2002062343A2 (en) 2001-02-02 2002-08-15 Merck Patent Gmbh PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
DE10121002A1 (de) 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
IL159218A0 (en) 2001-06-25 2004-06-01 Nissan Chemical Ind Ltd Substituted benzopyran derivatives against arrhythmia
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
MXPA05013549A (es) * 2003-06-11 2006-04-05 Xention Discovery Ltd Derivados de tienopirimidina como inhibidores del canal de potasio.
ZA200600197B (en) * 2003-07-02 2007-06-27 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
CA2552598A1 (en) 2004-01-06 2005-07-21 Taisho Pharmaceutical Co., Ltd. Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group
US7776867B2 (en) 2004-06-29 2010-08-17 Amgen Inc. Furanopyrimidines
EP1879899B1 (en) 2004-12-09 2010-08-04 Xention Limited Thienopyridine derivatives as potassium channel inhibitors
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
US20080108611A1 (en) 2006-01-19 2008-05-08 Battista Kathleen A Substituted thienopyrimidine kinase inhibitors
KR20090021218A (ko) * 2006-06-12 2009-02-27 버텍스 파마슈티칼스 인코포레이티드 이온 채널의 조절제로서 유용한 티에노피리미딘
DE102009039893B4 (de) 2009-09-03 2012-03-29 Bundesanstalt für Materialforschung und -Prüfung (BAM) Verwendung eines Brennstoffs in einem selbstunterhaltenden pulsierenden Sauerstoff-Brennstoff-Verbrennungsprozess

Also Published As

Publication number Publication date
GB201105659D0 (en) 2011-05-18
CN103492392A (zh) 2014-01-01
MX2013011301A (es) 2014-04-16
CA2831493A1 (en) 2012-10-04
EP2694518B1 (en) 2015-10-07
TW201244720A (en) 2012-11-16
CU24173B1 (es) 2016-04-25
AP2013007198A0 (en) 2013-10-31
HK1193806A1 (zh) 2014-10-03
DK2694518T3 (en) 2015-11-09
AR088735A1 (es) 2014-07-02
EA201301111A1 (ru) 2014-02-28
CY1117025T1 (el) 2017-04-05
NI201300100A (es) 2014-01-07
SMT201500322B (it) 2016-02-25
JP2014509637A (ja) 2014-04-21
MX335937B (es) 2016-01-04
NZ615621A (en) 2015-01-30
GT201300225A (es) 2014-12-30
ECSP13012988A (es) 2013-12-31
CR20130488A (es) 2013-12-06
PE20141021A1 (es) 2014-08-30
KR20140023332A (ko) 2014-02-26
RU2013148627A (ru) 2015-05-10
TN2013000377A1 (en) 2015-01-20
BR112013025236A2 (pt) 2019-09-24
MA35064B1 (fr) 2014-04-03
HUE028438T2 (en) 2017-02-28
AU2012235882B2 (en) 2015-08-06
TWI516265B (zh) 2016-01-11
US20140206703A1 (en) 2014-07-24
JP5826374B2 (ja) 2015-12-02
RS54458B1 (en) 2016-06-30
CU20130124A7 (es) 2014-01-29
CL2013002789A1 (es) 2014-07-18
WO2012131379A1 (en) 2012-10-04
US9249155B2 (en) 2016-02-02
SG193578A1 (en) 2013-10-30
CO6801756A2 (es) 2013-11-29
PT2694518E (pt) 2016-02-05
SI2694518T1 (sl) 2016-02-29
IL228555A0 (en) 2013-12-31
EP2694518A1 (en) 2014-02-12
ES2558563T3 (es) 2016-02-05
HRP20151340T1 (hr) 2016-02-26
HK1193096A1 (zh) 2014-09-12
ME02314B (me) 2016-06-20
CN103492392B (zh) 2015-11-25
PL2694518T3 (pl) 2016-03-31
AU2012235882A1 (en) 2013-05-02
ZA201307085B (en) 2015-04-29
PH12013501952A1 (en) 2018-04-11

Similar Documents

Publication Publication Date Title
PH12017502141A1 (en) Compounds and their methods of use
JOP20180103A1 (ar) مركب صيدلاني
CY1116987T1 (el) Συμπυκνωμενα ιμιδαζολυλιμιδαζολια ως αντιϊικες ενωσεις
MD20140136A2 (ru) Ингибиторы вируса гепатита С
PH12014502772A1 (en) Substituted tricyclic compounds as fgfr inhibitors
EA201290980A1 (ru) Производные 1-амино-2-циклопропилэтилбороновой кислоты
SG194469A1 (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors
UA109464C2 (ru) Спироксиндольные антагонисты mdm2
PH12015501609A1 (en) Phenicol antibacterials
UA109010C2 (en) Morpholino pyrividines and their use in therapy
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
IN2014CN04530A (ru)
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
CY1121238T1 (el) Παραγωγα παντοθενικου για την αντιμετωπιση νευρολογικων διαταραχων
UA110131C2 (ru) ПРОИЗВОДНЫЕ ТИЕНО[2,3-d]ПИРИМИДИНА И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ АРИТМИИ
EA201400444A1 (ru) Производные 2-оксопиперидинила
IN2015DN02109A (ru)
MX2014004742A (es) Nuevos agentes antibacterianos de fenicol.
PH12016502133A1 (en) Substituted tricycle compounds as fgfr inhibitors
TN2013000202A1 (en) Spiro-oxindole mdm2 antagonists